deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT04233489

Clinical Interventions to Mitigate Neurodevelopmental Risk

Sponsor: Columbia University

Updated 5 times since 2020 Last updated: Oct 11, 2022 Started: Jan 3, 2020 Primary completion: Mar 13, 2020 Completion: Mar 13, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The COVID-19 pandemic lead to halted protocols containing human subjects and in person interactions

This NA trial investigates Child Development and Diabetes Mellitus, Gestational and is currently terminated or withdrawn. Columbia University leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotNot Yet Recruiting~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 23 months · monthly snapshotTerminated

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Nov 2022 — Jul 2024 [monthly]

    Terminated NA

    Status: Not Yet RecruitingTerminated

  4. Jan 2021 — Nov 2022 [monthly]

    Not Yet Recruiting NA

  5. Feb 2020 — Jan 2021 [monthly]

    Not Yet Recruiting NA

    First recorded

Jan 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Columbia University
  • New York State Psychiatric Institute
Data source: Columbia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations